Sort
15,842 grants matching “pancreatic cancer”
Genetic Epidemiology of Melanoma
$637,867David E E Elder · University Of Pennsylvania · R01 · FY2009 · CA
Targeting Pancreatic Cancer
$637,815David L Morse · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2011 · CA
Development of a theragnostic radiopharmaceutical for pancreatic cancer
$637,798Katherine W Ferrara · Stanford University · R01 · FY2024 · CA
Role of MFG-E8 in Tumor Biology and Immunophysiology
$637,771Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
SIRT6 SUPPRESSES PANCREATIC CANCER VIA THE ONCOFETAL PROTEIN LIN28B
$637,743The General Hospital Corporation · · FY2017 · Department of the Army
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$637,418Chrystal Mary Paulos · Emory University · R01 · FY2023 · CA
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer
$637,390Anna E Lokshin · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument
$637,283Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA
Molecular Pathology of Pulmonary Carcinogenesis
$637,151Ilona Linnoila · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Neuro-immune regulation of intestinal inflammation
$636,952David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Neuro-immune regulation of intestinal inflammation
$636,952David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Neuro-immune regulation of intestinal inflammation
$636,952David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK
Neuro-immune regulation of intestinal inflammation
$636,952David Artis · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
$636,722Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Flexible Tools for Pre-Clinical Studies to Answer Key Questions UnderlyingHeavy-Ion Radiotherapy
$636,594David Jonathan Brenner · Columbia University Health Sciences · U01 · FY2022 · CA
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
$636,467Katherine W Ferrara · University Of California At Davis · R01 · FY2016 · CA
Image-guided ultrasound therapy and drug delivery in pancreatic cancer
$636,467Katherine W Ferrara · University Of California At Davis · R01 · FY2017 · CA
Large scale clinical and economic impact analysis of potentially malignant incidental findings in radiology reports
$636,424Meliha Yetisgen · University Of Washington · R01 · FY2022 · CA
Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics
$636,410Phil Crews · University Of California Santa Cruz · R01 · FY2017 · CA
Defining the oncogenic potential and therapeutic dependencies of PDAC-associated KRAS variants
$636,046Rohit Chandwani · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
A precision oncology approach to integrating of tumor microenvironment suppressive cell modulators to enhance antitumor immunity
$635,965Dung T Le · Johns Hopkins University · P01 · FY2024 · CA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$635,863Sterling M McPherson · Washington State University · R01 · FY2022 · AA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$635,863Sterling M McPherson · Washington State University · R01 · FY2023 · AA
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
$635,863Sterling M McPherson · Washington State University · R01 · FY2021 · AA
Novel Therapy to Inhibit IPMN Progression
$635,784Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA